Brain polar phenol content, behavioural and neurochemical effects of Corinthian currant in a rotenone rat model of Parkinson’s disease

References

• Cardoso S, Moreira P, Agostinho P, Pereira C, Oliveira C. Neurodegenerative pathways in Parkinsons disease: therapeutic strategies. Curr Drug Target CNS Neurol Disord. 2005;4:405–19. DOI:10.2174/1568007054546072.
   PubMedGoogle Scholar
• Hegarty SV, Lee DJ, O’Keeffe GW, Sullivan AM. Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson’s disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2017;38. DOI:10.1016/j.parkreldis.2017.02.011.
   PubMed Web of Science ®Google Scholar
• Sherer TB, Betarbet R, Testa CM, et al. Mechanism of toxicity in rotenone models of Parkinson’s disease. J Neurosci. 2003;23:10756–64. DOI:10.1523/JNEUROSCI.23-34-10756.2003.
   PubMed Web of Science ®Google Scholar
• Xiong N, Long X, Xiong J, et al. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models. Crit Rev Toxicol. 2012;42:613–32. DOI:10.3109/10408444.2012.680431.
   PubMed Web of Science ®Google Scholar
• Han Y, Wang T, Li C, et al. Ginsenoside Rg3 exerts a neuroprotective effect in rotenone-induced Parkinson’s disease mice via its anti-oxidative properties. Eur J Pharmacol. 2021;909:174413. DOI:10.1016/j.ejphar.2021.174413.
   PubMed Web of Science ®Google Scholar
• Nabavi SF, Sureda A, Dehpour AR, et al. Regulation of autophagy by polyphenols: paving the road for treatment of neurodegeneration. Biotechnol Adv. 2018;36:1768–78. DOI:10.1016/j.biotechadv.2017.12.001.
   PubMed Web of Science ®Google Scholar
• Kung H-C, Lin K-J, Kung C-T, Lin T-K. Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson’s disease. Biomedicines. 2021;9:918. DOI:10.3390/biomedicines9080918.
   PubMed Web of Science ®Google Scholar
• Lacerda DC, Urquiza-Martínez MV, Manhaes-de-Castro R, et al. Metabolic and neurological consequences of the treatment with polyphenols: a systematic review in rodent models of noncommunicable diseases. Nutr Neurosci. 2021: 1–17. DOI:10.1080/1028415X.2021.1891614.
   Web of Science ®Google Scholar
• Karuppagounder SS, Madathil SK, Pandey M, Haobam R, Rajamma U, Mohanakumar KP. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats. Neuroscience. 2013;236: 136–48. DOI:10.1016/j.neuroscience.2013.01.032.
   PubMed Web of Science ®Google Scholar
• Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: fruits. J Agric Food Chem. 2001;49. DOI:10.1021/jf0009293.
   PubMed Web of Science ®Google Scholar
• Kallithraka S, Mohdaly AA-A, Makris DP, Kefalas P. Determination of major anthocyanin pigments in Hellenic native grape varieties (Vitis vinifera sp.): association with antiradical activity. J Food Compos Anal. 2005;18:375–86. DOI:10.1016/j.jfca.2004.02.010.
   Web of Science ®Google Scholar
• Chiou A, Karathanos VT, Mylona A, Salta FN, Preventi F, Andrikopoulos NK. Currants (Vitis vinifera L.) content of simple phenolics and antioxidant activity. Food Chem. 2007;102:516–22. DOI:10.1016/J.FOODCHEM.2006.06.009.
   Web of Science ®Google Scholar
• Erlund I, Marniemi J, Hakala P, Alfthan G, Meririnne E, Aro A. Consumption of black currants, lingonberries and bilberries increases serum quercetin concentrations. Eur J Clin Nutr. 2003;57:37–42. DOI:10.1038/sj.ejcn.1601513.
   PubMed Web of Science ®Google Scholar
• Sarbishegi M, Charkhat Gorgich EA, Khajavi O, Komeili G, Salimi S. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson’s disease in rat. Metab Brain Dis. 2018;33:79–88. DOI:10.1007/s11011-017-0131-0.
   PubMed Web of Science ®Google Scholar
• Lever C, Burton S, Ο’Keefe J. Rearing on hind legs, environmental novelty, and the hippocampal formation. Rev Neurosci. 2006;17. DOI:10.1515/REVNEURO.2006.17.1-2.111.
   Web of Science ®Google Scholar
• Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. A highly reproducible rotenone model of Parkinson’s disease. Neurobiol Dis. 2009;34:279–90. DOI:10.1016/j.nbd.2009.01.016.
   PubMed Web of Science ®Google Scholar
• Crusio WE. Genetic dissection of mouse exploratory behaviour. Behav Brain Res. 2001;125:127–32. DOI:10.1016/S0166-4328(01)00280-7.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2007.
   Google Scholar
• Mountaki C, Dafnis I, Panagopoulou EA, et al. Mechanistic insight into the capacity of natural polar phenolic compounds to abolish Alzheimer’s disease-associated pathogenic effects of apoE4 forms. Free Radical Biol Med. 2021;171:284–301. DOI:10.1016/j.freeradbiomed.2021.05.022.
   PubMed Web of Science ®Google Scholar
• Perdikaris P, Tsarouchi M, Fanarioti E, Natsaridis E, Mitsacos A, Giompres P. Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain. Neuropharmacology. 2018;129:1–15. DOI:10.1016/j.neuropharm.2017.11.005.
   PubMed Web of Science ®Google Scholar
• Aryal S, Skinner T, Bridges B, Weber JT. The pathology of Parkinson’s disease and potential benefit of dietary polyphenols. Molecules. 2020;25:4382. DOI:10.3390/molecules25194382.
   PubMed Web of Science ®Google Scholar
• le Nedelec M, Glue P, Winter H, Goulton C, Broughton L, Medlicott N. Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations. Drug Deliv Transl Res. 2018;8:780–6. DOI:10.1007/s13346-017-0476-2.
   PubMed Web of Science ®Google Scholar
• Ko MJ, Mulia GE, van Rijn RM. Commonly used anesthesia/euthanasia methods for brain collection differentially impact MAPK activity in male and female C57BL/6 mice. Front Cell Neurosci. 2019;13. DOI:10.3389/fncel.2019.00096.
   Web of Science ®Google Scholar
• Kohtala S, Theilmann W, Rosenholm M, et al. Ketamine-induced regulation of TrkB-GSK3β signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites. Neuropharmacology. 2019;157:107684. DOI:10.1016/j.neuropharm.2019.107684.
   PubMed Web of Science ®Google Scholar
• Balakrishnan R, Vijayraja D, Mohankumar T, et al. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson’s disease. J Chem Neuroanat. 2021;112:101890. DOI:10.1016/j.jchemneu.2020.101890.
   PubMed Web of Science ®Google Scholar
• Ben Youssef S, Brisson G, Doucet-Beaupré H, et al. Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson’s disease. Nutr Neurosci. 2021;24:197–211. DOI:10.1080/1028415X.2019.1616435.
   PubMed Web of Science ®Google Scholar
• Wrangel CV, Schwabe K, John N, Krauss JK, Alam M. The rotenone-induced rat model of Parkinson’s disease: behavioral and electrophysiological findings. Behav Brain Res. 2015;279:52–61. DOI:10.1016/J.BBR.2014.11.002.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Gough B, Raymick J, et al. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: neuroprotective effects of acetyl-l-carnitine. Neurosci Lett. 2015;606:53–9. DOI:10.1016/j.neulet.2015.08.044.
   PubMed Web of Science ®Google Scholar
• Ferris CF, Marella M, Smerkers B, et al. A phenotypic model recapitulating the neuropathology of Parkinson’s disease. Brain Behav. 2013;3:351–66. DOI:10.1002/brb3.138.
   PubMed Web of Science ®Google Scholar
• Jin F, Wu Q, Lu Y-F, Gong Q-H, Shi J-S. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson’s disease in rats. Eur J Pharmacol. 2008;600. DOI:10.1016/j.ejphar.2008.10.005.
   PubMed Web of Science ®Google Scholar
• Haleagrahara N, Siew CJ, Mitra NK, Kumari M. Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum. Neurosci Lett. 2011;500:139–43. DOI:10.1016/j.neulet.2011.06.021.
   PubMed Web of Science ®Google Scholar
• Patil SP, Jain PD, Sancheti JS, Ghumatkar PJ, Tambe R, Sathaye S. Neuroprotective and neurotrophic effects of apigenin and luteolin in MPTP induced parkinsonism in mice. Neuropharmacology. 2014;86:192–202. DOI:10.1016/j.neuropharm.2014.07.012.
   PubMed Web of Science ®Google Scholar
• Ay M, Luo J, Langley M, et al. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson’s disease. J Neurochem. 2017;141. DOI:10.1111/jnc.14033.
   PubMed Web of Science ®Google Scholar
• Ishisaka A, Ichikawa S, Sakakibara H, et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radical Biol Med. 2011;51:1329–36. DOI:10.1016/j.freeradbiomed.2011.06.017.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Abbas Naqvi A, et al. Quantification of rutin in rat’s brain by UHPLC/ESI-Q-TOF-MS/MS after intanasal administration of rutin loaded chitosan nanoparticles. EXCLI J. 2016;15:518–31. DOI:10.17179/excli2016-361.
   PubMed Web of Science ®Google Scholar
• Hor SL, Teoh SL, Lim WL. Plant polyphenols as neuroprotective agents in Parkinson’s disease targeting oxidative stress. Curr Drug Targets. 2020;21. DOI:10.2174/1389450120666191017120505.
   PubMed Web of Science ®Google Scholar
• Nimse SB, Pal D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv. 2015;5:27986–8006. DOI:10.1039/C4RA13315C.
   Web of Science ®Google Scholar
• di Meo F, Lemaur V, Cornil J, et al. Free radical scavenging by natural polyphenols: atom versus electron transfer. J Phys Chem A. 2013;117:2082–92. DOI:10.1021/jp3116319.
   PubMed Web of Science ®Google Scholar
• Banji D, Banji OJF, Srinivas K. Neuroprotective effect of turmeric extract in combination with its essential oil and enhanced brain bioavailability in an animal model. BioMed Res Int. 2021;2021:1–12. DOI:10.1155/2021/6645720.
   PubMed Web of Science ®Google Scholar
• Patsoukis N, Papapostolou I, Zervoudakis G, Georgiou CD, Matsokis NA, Panagopoulos NT. Thiol redox state and oxidative stress in midbrain and striatum of weaver mutant mice, a genetic model of nigrostriatal dopamine deficiency. Neurosci Lett. 2005;376:24–8. DOI:10.1016/j.neulet.2004.11.019.
   PubMed Web of Science ®Google Scholar
• Cardoso HD, Passos PP, Lagranha CJ, et al. Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids. Front Hum Neurosci. 2012;6. DOI:10.3389/fnhum.2012.00249.
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang J, Hu S, Wang R, Mao Y, Xie J. Neuroprotective effect of resveratrol on rotenone-treated C57BL/6 mice. NeuroReport. 2017;28. DOI:10.1097/WNR.0000000000000789.
   Web of Science ®Google Scholar
• Kujawska M, Jodynis-Liebert J. Polyphenols in Parkinson’s disease: A systematic review of in vivo studies. Nutrients. 2018;10. DOI:10.3390/nu10050642.
   Web of Science ®Google Scholar
• Jenner P, Warren Olanow C. Understanding cell death in Parkinson’s disease. Ann Neurol. 1998;44:S72–S84. DOI:10.1002/ana.410440712.
   PubMed Web of Science ®Google Scholar
• Fumagalli F, Racagni G, Riva MA. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson’s disease. Pharmacogenomics J. 2006;6. DOI:10.1038/sj.tpj.6500360.
   Web of Science ®Google Scholar
• Hyman C, Hofer M, Barde Y-A, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991;350:230–2. DOI:10.1038/350230a0.
   PubMed Web of Science ®Google Scholar
• Johnson ME, Zhou X-F, Bobrovskaya L. The effects of rotenone on TH, BDNF and BDNF-related proteins in the brain and periphery: relevance to early Parkinson’s disease. J Chem Neuroanat. 2019;97:23–32. DOI:10.1016/j.jchemneu.2019.01.010.
   PubMed Web of Science ®Google Scholar
• Parain K, Murer MG, Yan Q, et al. Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. NeuroReport. 1999;10:557–61. DOI:10.1097/00001756-199902250-00021.
   PubMed Web of Science ®Google Scholar
• Weissmiller AM, Wu C. Current advances in using neurotrophic factors to treat neurodegenerative disorders. Transl Neurodegener. 2012;1. DOI:10.1186/2047-9158-1-14.
   PubMedGoogle Scholar
• Gravesteijn E, Mensink RP, Plat J. Effects of nutritional interventions on BDNF concentrations in humans: a systematic review. Nutr Neurosci. 2021. DOI:10.1080/1028415X.2020.1865758.
   PubMed Web of Science ®Google Scholar